Caldic B.V.’s Acquisition of Brand-Nu Laboratories and BNL Sciences

Arthur Cox, together with Hogan Lovells, advised Caldic B.V..

Caldic B.V. has entered into a definitive agreement to acquire Brand-Nu Laboratories Inc. and BNL Sciences Ltd., two value-add distributors of specialty chemicals for the pharmaceutical and biopharmaceutical industries located in the US and Ireland.

The acquisitions underline Caldic’s ambition to further expand its presence in the fast growing, resilient pharma and biopharma markets.

Brand-Nu is a privately-owned business that was founded in 1956. Located in Meriden, Connecticut, USA, the company focuses on the distribution of high purity specialty chemicals, excipients and biological raw materials to a broad range of customers in the pharmaceutical, biopharmaceutical, medical device, microelectronic materials and specialty chemical markets.

BNL Sciences is a first mover in Ireland and a go to partner for biopharma and medical device customers producing drugs and medical devices in Europe.

The Arthur Cox team was led by Connor Manning and Cian McCourt (Picture, Corporate and M&A) and included Dannie Hanna and Jean Kiely (Corporate and M&A), Deirdre Sheehan and Lucy Byrne (Real Estate), Imelda Shiels and Julianne McNicholas (Finance), Cian Beecher and Declan MacQuillan (Employment), Sarah McCague and Katie Lawless (Pensions) and Richard Ryan, Simon Breen and Edel O’Connell (Competition).

Involved fees earner: Cian Beecher – Arthur Cox; Simon Breen – Arthur Cox; Lucy Byrne – Arthur Cox; Dannie Hanna – Arthur Cox; Jean Kiely – Arthur Cox; Katie Lawless – Arthur Cox; Declan MacQuillan – Arthur Cox; Connor Manning – Arthur Cox; Sarah McCague – Arthur Cox; Cian McCourt – Arthur Cox; Julianne McNicholas – Arthur Cox; Edel O’Connell – Arthur Cox; Richard Ryan – Arthur Cox; Deirdre Sheehan – Arthur Cox; Imelda Shiels – Arthur Cox;

Law Firms: Arthur Cox;

Clients: Caldic;